Abatacept, Adalimumab Equal for RA in Head-to-Head Trial Abatacept, Adalimumab Equal for RA in Head-to-Head Trial
Subcutaneous abatacept and subcutaneous adalimumab were comparably effective when added to background methotrexate for patients with rheumatoid arthritis who had no previous exposure to biologicals. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news
More News: Abatacept | Arthritis | Health | Humira | Methotrexate | Orencia | Rheumatoid Arthritis | Rheumatology